abstract |
This application relates to phthalazine derivatives of formula (I) which are useful for the treatment of cancer by inhibiting PARP1, PARP2 and / or tubulin. Also disclosed are pharmaceutical formulations comprising such compounds, as well as combinations of these compounds with at least one additional therapeutic agent. (I) |